Torren Management »

Lexeo Therapeutics shares owned by Torren Management

Quarter-by-quarter ownership of Lexeo Therapeutics (LXEO) shares owned by Torren Management from 13F filings

Historical chart of Torren Management investment in Lexeo Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lexeo Therapeutics held by Torren Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexeo Therapeutics by Torren Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.0k 178 5.74

More positions owned by Torren Management

Avantis Total Equity Markets Etf Etf (AVTM)
Avantis U.S. Equity ETF Etf (AVUS)
Avantis International Equity ETF Etf (AVDE)
Dimensional Short-Duration Fixed Income ETF Etf (DFSD)
Avantis U.S. Quality ETF Etf (AVUQ)
Dimensional Core Fixed Income ETF Etf (DFCF)
Avantis Emerging Markets Equity ETF Etf (AVEM)
Avantis U.S. Small Cap Value ETF Etf (AVUV)
Dimensional Global ex US Core Fixed Income ETF Etf (DFGX)
Dimensional Ultrashort Fixed Income ETF Etf (DUSB)
Dimensional US High Profitability ETF Etf (DUHP)
Dimensional International Core Equity 2 ETF Etf (DFIC)
PIMCO 15 Year U.S. TIPS Index ETF Etf (LTPZ)
Dimensional US Core Equity 2 ETF Etf (DFAC)
Dimensional International High Profitability ETF Etf (DIHP)

View all positions for Torren Management

Top funds holding Lexeo Therapeutics

Paradigm Biocapital Advisors
BlackRock
RA Capital Management
Henderson Group
Vestal Point Capital
Frazier Life Sciences Management
Vanguard Group
Citadel Advisors
OrbiMed Advisors
venBio Select Advisor
Affinity Asset Advisors
State Street Corporation
Vanguard Capital Management
Woodline Partners
Goldman Sachs Group

View all funds holding Lexeo Therapeutics